Schwabish Marc has filed 16 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 19500 shares of Tectonic Therapeutic, Inc. ($TECX) on March 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Common Stock | 19500 | $0.00 | 45,314.0000 | 18,716,280 | 75.54% | 0.10% |
| March 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 17750 | $0.00 | 17,750.0000 | 18,716,280 | 9999.99% | 0.09% |
| Feb. 10, 2026 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | M | Employee Stock Option (Right to Buy) | 4500 | $0.00 | 82,014.0000 | 18,716,280 | 5.20% | 0.02% |
| Feb. 10, 2026 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | M | Common Stock | 4500 | $2.38 | 25,814.0000 | 18,716,280 | 21.11% | 0.02% |
| Feb. 4, 2026 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | F | Common Stock | 1619 | $23.22 | 21,314.0000 | 18,716,280 | 7.06% | 0.01% |
| Sept. 25, 2025 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 7650 | $0.00 | 7,650.0000 | 18,662,672 | 9999.99% | 0.04% |
| Sept. 25, 2025 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Common Stock | 4210 | $0.00 | 22,933.0000 | 18,662,672 | 22.49% | 0.02% |
| Feb. 4, 2025 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Common Stock | 14023 | $0.00 | 18,723.0000 | 0 | 298.36% | 0.00% |
| Feb. 4, 2025 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 25496 | $0.00 | 25,496.0000 | 0 | 9999.99% | 0.00% |
| Jan. 28, 2025 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | M | Employee Stock Option (Right to Buy) | 2700 | $0.00 | 86,514.0000 | 0 | 3.03% | 0.00% |
| Jan. 28, 2025 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | M | Common Stock | 2700 | $2.38 | 4,700.0000 | 0 | 135.00% | 0.00% |
| Dec. 9, 2024 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | M | Employee Stock Option (Right to Buy) | 2000 | $0.00 | 89,214.0000 | 0 | 2.19% | 0.00% |
| Dec. 9, 2024 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | M | Common Stock | 2000 | $2.38 | 2,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 8016 | $0.00 | 8,016.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 91214 | $0.00 | 91,214.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Tectonic Therapeutic, Inc. | $TECX | Schwabish Marc | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 61600 | $0.00 | 61,600.0000 | 0 | 9999.99% | 0.00% |